10-May-2024
No headlines found.
Globe Newswire (Thu, 25-Apr 7:00 AM ET)
Globe Newswire (Mon, 8-Apr 7:00 AM ET)
Globe Newswire (Wed, 3-Apr 7:00 AM ET)
Eyenovia Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Globe Newswire (Mon, 18-Mar 4:05 PM ET)
Globe Newswire (Wed, 13-Mar 7:00 AM ET)
Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th
Globe Newswire (Mon, 11-Mar 7:00 AM ET)
Globe Newswire (Tue, 5-Mar 8:00 AM ET)
PRNewswire (Mon, 4-Mar 5:55 PM ET)
Eyenovia Announces FDA Approval of Redwood City as Commercial Manufacturing Facility
Globe Newswire (Tue, 13-Feb 7:00 AM ET)
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Eyenovia trades on the NASDAQ stock market under the symbol EYEN.
As of May 10, 2024, EYEN stock price declined to $0.77 with 594,680 million shares trading.
EYEN has a beta of 2.68, meaning it tends to be more sensitive to market movements. EYEN has a correlation of 0.07 to the broad based SPY ETF.
EYEN has a market cap of $39.30 million. This is considered a Sub-Micro Cap stock.
Last quarter Eyenovia reported $2,589 in Revenue and -$.18 earnings per share. This fell short of revenue expectation by $-127,411 and missed earnings estimates by -$.01.
In the last 3 years, EYEN stock traded as high as $6.63 and as low as $.50.
The top ETF exchange traded funds that EYEN belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
EYEN has underperformed the market in the last year with a return of -82.2%, while the SPY ETF gained +27.8%. In the last 3 month period, EYEN fell short of the market, returning -57.9%, while SPY returned +4.2%. However, in the most recent 2 weeks EYEN has outperformed the stock market by returning +22.8%, while SPY returned +2.5%.
EYEN support price is $.73 and resistance is $.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EYEN stock will trade within this expected range on the day.